Thymoquinone Inhibits Autophagy and Induces Cathepsin-Mediated, Caspase-Independent Cell Death in Glioblastoma Cells

作者: Ira O. Racoma , Walter Hans Meisen , Qi-En Wang , Balveen Kaur , Altaf A. Wani

DOI: 10.1371/JOURNAL.PONE.0072882

关键词:

摘要: Glioblastoma is the most aggressive and common type of malignant brain tumor in humans, with a median survival 15 months. There great need for more therapies treatment glioblastoma. Naturally occurring phytochemicals have received much scientific attention because many exhibit potent killing action. Thymoquinone (TQ) bioactive compound Nigella sativa seed oil. TQ has anti-oxidant, anti-inflammatory anti-neoplastic actions selective cytotoxicity human cancer cells compared to normal cells. Here, we show that selectively inhibits clonogenicity glioblastoma as astrocytes. Also, cell proliferation could be impaired by chloroquine, an autophagy inhibitor, suggesting may dependent on autophagic pathway survival. Exposure caused increase recruitment accumulation microtubule-associated protein light chain 3-II (LC3-II). also LC3-associated p62, confirming inhibition autophagy. Furthermore, levels Beclin-1 expression were unchanged, indicating interferes later stage Finally, induces lysosome membrane permeabilization, determined specific loss red acridine orange staining. Lysosome permeabilization resulted leakage cathepsin B into cytosol, which mediates caspase-independent death can prevented pre-treatment inhibitor. induced apoptosis, PI Annexin V positive However, apoptosis appears due failure caspase inhibitor z-VAD-FMK prevent absence typical related signature DNA fragmentation. Inhibition exciting emerging strategy therapy. In this vein, our results describe novel mechanism action targeting

参考文章(64)
Josianne Al-Hmaira, Hala Gali-Muhtasib, Roland Hartig, Albert Roessner, Mona Diab-Assaf, Carsten Boltze, Regine Schneider-Stock, Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. International Journal of Oncology. ,vol. 25, pp. 857- 866 ,(2004) , 10.3892/IJO.25.4.857
Noboru Mizushima, Tamotsu Yoshimori, How to Interpret LC3 Immunoblotting Autophagy. ,vol. 3, pp. 542- 545 ,(2007) , 10.4161/AUTO.4600
El-Shaimaa A. Arafa, Qianzheng Zhu, Bassant M. Barakat, Gulzar Wani, Qun Zhao, Mohamed A. El-Mahdy, Altaf A. Wani, Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Research. ,vol. 69, pp. 8910- 8917 ,(2009) , 10.1158/0008-5472.CAN-09-1543
Boris Turk, Vito Turk, Lysosomes as ‘suicide bags’ in cell death: myth or reality? Journal of Biological Chemistry. ,vol. 284, pp. 21783- 21787 ,(2009) , 10.1074/JBC.R109.023820
Nahed El-Najjar, Raimo A. Ketola, Teemu Nissilä, Timo Mauriala, Maxim Antopolsky, Janne Jänis, Hala Gali-Muhtasib, Arto Urtti, Heikki Vuorela, Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone. Journal of Chemical Biology. ,vol. 4, pp. 97- 107 ,(2011) , 10.1007/S12154-010-0052-4
Ahmed Shoieb, Mona Elgayyar, Paul Dudrick, John Bell, Patricia Tithof, In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone International Journal of Oncology. ,vol. 22, pp. 107- 113 ,(2003) , 10.3892/IJO.22.1.107
El-Shaimaa A. Arafa, Qianzheng Zhu, Zubair I. Shah, Gulzar Wani, Bassant M. Barakat, Ira Racoma, Mohamed A. El-Mahdy, Altaf A. Wani, Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutation Research. ,vol. 706, pp. 28- 35 ,(2011) , 10.1016/J.MRFMMM.2010.10.007
Stephanie L. Lomonaco, Susan Finniss, Cunli Xiang, Ana DeCarvalho, Felix Umansky, Steven N. Kalkanis, Tom Mikkelsen, Chaya Brodie, The induction of autophagy by γ-radiation contributes to the radioresistance of glioma stem cells International Journal of Cancer. ,vol. 125, pp. 717- 722 ,(2009) , 10.1002/IJC.24402
Takao Kanzawa, Joshua Bedwell, Yasuko Kondo, Seiji Kondo, Isabelle M. Germano, Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide Journal of Neurosurgery. ,vol. 99, pp. 1047- 1052 ,(2003) , 10.3171/JNS.2003.99.6.1047